The price offered for each share validly tendered into the Tender Offer will be EUR 0.2946 in cash http://aravisventures.com/news/2016/01/aravis-biotech-ii-another-exit https://www.genengnews.com/news/acorda-acquires-biotie-therapies-for-363m/ https://en.wikipedia.org/wiki/Biotie_Therapies